Premium
Aktis Oncology Inc (AKTS)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is... Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company’s lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced or metastatic urothelial cancer, breast cancer, NSCLC, colorectal cancer and cervical cancer; and [225Ac]Ac-AKY-2519 to deliver 225Ac to B7-H3 (CD276) expressing tumors, including prostate, lung and other solid tumors. It has license and collaboration agreements with Protein Innovation, Inc., TRIUMF Innovations, Inc., and Eli Lilly. The company was formerly known as HotKnot Therapeutics, Inc. and changed its name to Aktis Oncology, Inc. in April 2020. Aktis Oncology, Inc. was incorporated in 2020 and is headquartered in Boston, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.57 | -7.68101761252 | 20.44 | 21.12 | 18.52 | 194406 | 19.94639542 | CS |
| 4 | 0.07 | 0.372340425532 | 18.8 | 21.2 | 17.88 | 154468 | 19.5707924 | CS |
| 12 | 0.79 | 4.36946902655 | 18.08 | 23.05 | 14.72 | 265045 | 18.58395427 | CS |
| 26 | 18.8328 | 50625.8064516 | 0.0372 | 23.9999 | 0.0372 | 210779 | 19.15701753 | CS |
| 52 | 18.8328 | 50625.8064516 | 0.0372 | 23.9999 | 0.0372 | 104130 | 19.15701753 | CS |
| 156 | 15.59 | 475.304878049 | 3.28 | 23.9999 | 0.033 | 3959722 | 0.3600422 | CS |
| 260 | 8.72 | 85.9113300493 | 10.15 | 23.9999 | 0.033 | 2587258 | 0.77120015 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
